Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$614K Buy
21,855
+57
+0.3% +$1.52K 0.24% 74
2025
Q4
$543K Buy
21,798
+2,151
+11% +$54.2K 0.22% 81
2025
Q3
$501K Buy
19,647
+610
+3% +$15.1K 0.21% 82
2025
Q2
$461K Buy
19,037
+932
+5% +$21.7K 0.21% 86
2025
Q1
$459K Buy
18,105
+7,325
+68% +$192K 0.23% 80
2024
Q4
$286K Sell
10,780
-1,276
-11% -$34.6K 0.14% 108
2024
Q3
$349K Sell
12,056
-3,066
-20% -$89.4K 0.17% 97
2024
Q2
$423K Sell
15,122
-712
-4% -$19.6K 0.22% 82
2024
Q1
$439K Sell
15,834
-73
-0.5% -$2.03K 0.23% 80
2023
Q4
$458K Sell
15,907
-1,218
-7% -$36.8K 0.26% 80
2023
Q3
$568K Buy
17,125
+506
+3% +$17.9K 0.35% 65
2023
Q2
$610K Sell
16,619
-606
-4% -$23.6K 0.36% 62
2023
Q1
$703K Buy
17,225
+52
+0.3% +$2.25K 0.44% 58
2022
Q4
$880K Buy
17,173
+102
+0.6% +$4.89K 0.58% 48
2022
Q3
$747K Buy
17,071
+2
+0% +$97 0.54% 49
2022
Q2
$895K Buy
17,069
+9
+0.1% +$459 0.62% 43
2022
Q1
$883K Sell
17,060
-1,250
-7% -$64.9K 0.55% 52
2021
Q4
$1.08M Buy
18,310
+3,584
+24% +$178K 0.67% 41
2021
Q3
$633K Buy
14,726
+192
+1% +$8.51K 0.47% 59
2021
Q2
$569 Buy
14,534
+137
+1% +$5.33K 0.26% 68
2021
Q1
$522 Buy
+14,397
New +$511K 0.29% 68

Other funds holding PFE

MBA Advisors's PFE Position: Q1 2026 in Review

MBA Advisors increased its Pfizer (PFE) stake by 0.26% in Q1 2026, buying an estimated $1.52K and bringing the position to 21,855 shares worth $614K. The position accounts for 0.24% of the portfolio, ranked #74.

MBA Advisors first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.08M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MBA Advisors held 21,855 shares of Pfizer worth $614K as of Q1 2026.
  • MBA Advisors bought 57 Pfizer shares in Q1 2026, an estimated $1.52K.
  • Pfizer made up 0.24% of MBA Advisors's portfolio in Q1 2026, its #74 holding.
  • MBA Advisors first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
  • MBA Advisors's Pfizer position peaked at $1.08M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.